Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2023-03-16 | 2023-03-10 |
| Drug Identification Number | 02239208 | 02239208 |
| Brand name | PRIORIX | PRIORIX |
| Common or Proper name | Combined measles, mumps and rubella vaccine, live, attenuated | Combined measles, mumps and rubella vaccine, live, attenuated |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | WATER RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED | WATER RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 0.5ML 1000CCID50 1000CCID50 10000CCID50 | 0.5ML 1000CCID50 1000CCID50 10000CCID50 |
| Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAMUSCULAR INTRAMUSCULAR SUBCUTANEOUS | SUBCUTANEOUS INTRAMUSCULAR INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 10s | 10s |
| ATC code | J07BD | J07BD |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2023-02-22 | 2023-02-22 |
| Estimated end date | 2023-03-17 | 2023-03-17 |
| Actual end date | 2023-03-15 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Limited supply available for public programs. Supply unavailable for the private market. | Limited supply available for public programs. Supply unavailable for the private market. |
| Health Canada comments |